Advent France Biotechnology's Chairman and Managing Partner, Alain Huriez, is an established figure in the biotechnology industry. Huriez has founded several biotech companies, including TcLand Expression, Effimune, and NEOVACS, and is a highly experienced venture capitalist. Behind his business acumen and investment strategies is an academic background that includes a Doctor of Medicine degree from Université de Picardie Jules Verne and a Master's degree from University of Paris I: Panthéon-Sorbonne in Pharmaco Economics. Huriez also served as Vice President Europe Biotechnology at Quintiles, where he honed his skills as an International Project Manager and Project Director at PSI CRO AG. Furthermore, Huriez has served as Founder and Chairman of EPEMED, Venture Partner at Advent Life Sciences LLP, and Associate Partner at Truffle Capital.